Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study.

about

Socioeconomic disparities and comorbidities, not race, affect salivary gland malignancy survival outcomes.Breast Cancer Risk Assessment Using the Gail Model and It’s Predictors in Saudi Women Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women.

P2860

Q46255167-7E7554BF-EECF-4084-A974-369D8F832418 Q47207420-E7BFD398-6E49-4013-B339-3FEF106B1A71 Q47733514-F998A6F5-90F8-4409-B460-DCCAA6BF1764

P2860

Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study.

Item

http://www.wikidata.org/entity/Q37454802

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Prevalence of chemopreventive ...... ncer: a cross-sectional study.

@en

Prevalence of chemopreventive ...... ncer: a cross-sectional study.

@nl

type

Item

label

Prevalence of chemopreventive ...... ncer: a cross-sectional study.

@en

Prevalence of chemopreventive ...... ncer: a cross-sectional study.

@nl

prefLabel

Prevalence of chemopreventive ...... ncer: a cross-sectional study.

@en

Prevalence of chemopreventive ...... ncer: a cross-sectional study.

@nl

P1476

Prevalence of chemopreventive ...... ncer: a cross-sectional study.

@en

P2093

Danijela Jelovac

http://www.w3.org/2001/XMLSchema#string

Scott M Wright

http://www.w3.org/2001/XMLSchema#string

Waseem Khaliq

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for the primary prevention of cardiovascular disease

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

Current strategies for the prevention of breast cancer

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.

Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement.

Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.

P304

e012550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2016-012550

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27852714

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

P932

5129040

http://www.w3.org/2001/XMLSchema#string

Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study.

about

P2860

P2860

Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932